Literature DB >> 33153587

Cardio-Oncology Education and Training: JACC Council Perspectives.

Jose A Alvarez-Cardona1, Jordan Ray2, Joseph Carver3, Vlad Zaha4, Richard Cheng5, Eric Yang6, Joshua D Mitchell1, Keith Stockerl-Goldstein7, Lavanya Kondapalli8, Susan Dent9, Anita Arnold10, Sherry Ann Brown11, Monica Leja12, Ana Barac13, Daniel J Lenihan1, Joerg Herrmann14.   

Abstract

The innovative development of cancer therapies has led to an unprecedented improvement in survival outcomes and a wide array of treatment-related toxicities, including those that are cardiovascular in nature. Aging of the population further adds to the number of patients being treated for cancer, especially those with comorbidities. Such pre-existing and developing cardiovascular diseases pose some of the greatest risks of morbidity and mortality in patients with cancer. Addressing the complex cardiovascular needs of these patients has become increasingly important, resulting in an imperative for an intersecting discipline: cardio-oncology. Over the past decade, there has been a remarkable rise of cardio-oncology clinics and service lines. This development, however, has occurred in a vacuum of standard practice and training guidelines, although these are being actively pursued. In this council perspective document, the authors delineate the scope of practice in cardio-oncology and the proposed training requirements, as well as the necessary core competencies. This document also serves as a roadmap toward confirming cardio-oncology as a subspecialty in medicine.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  cancer; cardio-oncology; cardiotoxicity; training

Mesh:

Year:  2020        PMID: 33153587      PMCID: PMC8174559          DOI: 10.1016/j.jacc.2020.08.079

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  47 in total

1.  Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy.

Authors:  D Cardinale; M T Sandri; A Martinoni; A Tricca; M Civelli; G Lamantia; S Cinieri; G Martinelli; C M Cipolla; C Fiorentini
Journal:  J Am Coll Cardiol       Date:  2000-08       Impact factor: 24.094

2.  The compelling need for a cardiology and oncology partnership and the birth of the International CardiOncology Society.

Authors:  Daniel J Lenihan; Daniela Cardinale; Carlo M Cipolla
Journal:  Prog Cardiovasc Dis       Date:  2010 Sep-Oct       Impact factor: 8.194

3.  Is it time to include cancer in cardiovascular risk prediction tools?

Authors:  Anne H Blaes; Chetan Shenoy
Journal:  Lancet       Date:  2019-08-20       Impact factor: 79.321

4.  Comprehensive Echocardiographic Detection of Treatment-Related Cardiac Dysfunction in Adult Survivors of Childhood Cancer: Results From the St. Jude Lifetime Cohort Study.

Authors:  Gregory T Armstrong; Vijaya M Joshi; Kirsten K Ness; Thomas H Marwick; Nan Zhang; DeoKumar Srivastava; Brian P Griffin; Richard A Grimm; James Thomas; Dermot Phelan; Patrick Collier; Kevin R Krull; Daniel A Mulrooney; Daniel M Green; Melissa M Hudson; Leslie L Robison; Juan Carlos Plana
Journal:  J Am Coll Cardiol       Date:  2015-06-16       Impact factor: 24.094

5.  Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

Authors:  Juan Carlos Plana; Maurizio Galderisi; Ana Barac; Michael S Ewer; Bonnie Ky; Marielle Scherrer-Crosbie; Javier Ganame; Igal A Sebag; Deborah A Agler; Luigi P Badano; Jose Banchs; Daniela Cardinale; Joseph Carver; Manuel Cerqueira; Jeanne M DeCara; Thor Edvardsen; Scott D Flamm; Thomas Force; Brian P Griffin; Guy Jerusalem; Jennifer E Liu; Andreia Magalhães; Thomas Marwick; Liza Y Sanchez; Rosa Sicari; Hector R Villarraga; Patrizio Lancellotti
Journal:  J Am Soc Echocardiogr       Date:  2014-09       Impact factor: 5.251

Review 6.  A Changing Landscape in Cardiovascular Research Publication Output: Bridging the Translational Gap.

Authors:  Diane Gal; Bart Thijs; Wolfgang Glänzel; Karin R Sipido
Journal:  J Am Coll Cardiol       Date:  2018-04-10       Impact factor: 24.094

7.  Atrial fibrillation after operation for lung cancer: clinical and prognostic significance.

Authors:  D Cardinale; A Martinoni; C M Cipolla; M Civelli; G Lamantia; C Fiorentini; M Mezzetti
Journal:  Ann Thorac Surg       Date:  1999-11       Impact factor: 4.330

8.  Cardiovascular Education Science: A Worthy Pursuit for Fellows-in-Training and Early Career Cardiologists?

Authors:  Michael W Cullen
Journal:  J Am Coll Cardiol       Date:  2019-11-05       Impact factor: 24.094

9.  Practices in management of cancer treatment-related cardiovascular toxicity: A cardio-oncology survey.

Authors:  Ludovic Jovenaux; Jennifer Cautela; Noemie Resseguier; Michele Pibarot; Myriam Taouqi; Morgane Orabona; Johan Pinto; Michael Peyrol; Jeremie Barraud; Marc Laine; Laurent Bonello; Franck Paganelli; Fabrice Barlesi; Franck Thuny
Journal:  Int J Cardiol       Date:  2017-03-21       Impact factor: 4.164

10.  Rapid Advances in Immunotherapy to Treat Cancer.

Authors:  Jeannine S McCune
Journal:  Clin Pharmacol Ther       Date:  2018-04       Impact factor: 6.875

View more
  15 in total

Review 1.  Training and Career Development in Cardio-Oncology Translational and Implementation Science.

Authors:  Sherry-Ann Brown; Eric H Yang; Mary Branch; Craig Beavers; Anne Blaes; Michael G Fradley; Richard K Cheng
Journal:  Heart Fail Clin       Date:  2022-07       Impact factor: 2.828

2.  Case Report: Oxaliplatin-Induced Third-Degree Atrioventricular Block: First Discovery of an Important Side-Effect.

Authors:  Xi Chen; Hui Wang; Zijin Zhang; Yan Xu; Xuanqi An; Xin Ai; Lin Li
Journal:  Front Cardiovasc Med       Date:  2022-06-27

3.  Atrial Cardiomyopathy Predicts Worse Outcome in Patients With Lung Cancer.

Authors:  Mengdi Ren; Yuyan Ma; Meng Wei; Yuye Ning; Hui Liu; Xue Shi; Yu Yao; Fengwei Guo
Journal:  Front Cardiovasc Med       Date:  2022-07-01

4.  Osimertinib and anti-HER3 combination therapy engages immune dependent tumor toxicity via STING activation in trans.

Authors:  J M Vicencio; R Evans; R Green; Z An; J Deng; C Treacy; R Mustapha; J Monypenny; C Costoya; K Lawler; K Ng; K De-Souza; O Coban; V Gomez; J Clancy; S H Chen; A Chalk; F Wong; P Gordon; C Savage; C Gomes; T Pan; G Alfano; L Dolcetti; J N E Chan; F Flores-Borja; P R Barber; G Weitsman; D Sosnowska; E Capone; S Iacobelli; D Hochhauser; J A Hartley; M Parsons; J N Arnold; S Ameer-Beg; S A Quezada; Y Yarden; G Sala; T Ng
Journal:  Cell Death Dis       Date:  2022-03-28       Impact factor: 9.685

5.  Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement.

Authors:  Joerg Herrmann; Daniel Lenihan; Saro Armenian; Ana Barac; Anne Blaes; Daniela Cardinale; Joseph Carver; Susan Dent; Bonnie Ky; Alexander R Lyon; Teresa López-Fernández; Michael G Fradley; Sarju Ganatra; Giuseppe Curigliano; Joshua D Mitchell; Giorgio Minotti; Ninian N Lang; Jennifer E Liu; Tomas G Neilan; Anju Nohria; Rupal O'Quinn; Iskra Pusic; Charles Porter; Kerry L Reynolds; Kathryn J Ruddy; Paaladinesh Thavendiranathan; Peter Valent
Journal:  Eur Heart J       Date:  2022-01-31       Impact factor: 35.855

6.  Long-term follow-up assessment of cardiac safety in SAFE-HEaRt, a clinical trial evaluating the use of HER2-targeted therapies in patients with breast cancer and compromised heart function.

Authors:  Katia Khoury; Filipa Lynce; Ana Barac; Xue Geng; Chau Dang; Anthony F Yu; Karen L Smith; Christopher Gallagher; Paula R Pohlmann; Raquel Nunes; Pia Herbolsheimer; Robert Warren; Monvadi B Srichai; Mark Hofmeyer; Federico Asch; Ming Tan; Claudine Isaacs; Sandra M Swain
Journal:  Breast Cancer Res Treat       Date:  2021-01-05       Impact factor: 4.872

7.  Perceptions of the Cardiologists and Oncologists: Initial Step for Establishing Cardio-Oncology Service.

Authors:  Hasan Ali Farhan; Israa Fadhil Yaseen
Journal:  Front Cardiovasc Med       Date:  2021-11-24

Review 8.  Cardio-oncology Training in the COVID-19 Era.

Authors:  Stephanie Feldman; Jennifer Liu; Richard Steingart; Dipti Gupta
Journal:  Curr Treat Options Oncol       Date:  2021-06-07

Review 9.  The Johns Hopkins Ciccarone Center's expanded 'ABC's approach to highlight 2020 updates in cardiovascular disease prevention.

Authors:  David I Feldman; Katherine C Wu; Allison G Hays; Francoise A Marvel; Seth S Martin; Roger S Blumenthal; Garima Sharma
Journal:  Am J Prev Cardiol       Date:  2021-04-05

10.  Long-Term Cardiac Damage Associated With Abdominal Irradiation in Mice.

Authors:  Zhaojia Wang; Ziheng Jia; Zandong Zhou; Xiaotong Zhao; Feng Wang; Xu Zhang; Gary Tse; Guangping Li; Yang Liu; Tong Liu
Journal:  Front Pharmacol       Date:  2022-02-22       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.